Variant report

Variant	rs16830662
Chromosome Location	chr2:152903317-152903318
allele	A/C
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr2:152890211..152893182-chr2:152902198..152904642,2	K562	blood:

Extended variants
information (count: 11 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:3)

rs_ID	r²[population]
rs72998994	1.00[AFR][1000 genomes]
rs7558695	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes]
rs950247	0.96[YRI][hapmap];0.89[AFR][1000 genomes];1.00[AMR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1005746	chr2:152361972-153059840	Strong transcription Weak transcription Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
2	nsv535984	chr2:152361972-153059840	Active TSS Weak transcription Enhancers Strong transcription Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
3	esv3693431	chr2:152683731-152981827	Enhancers Active TSS Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	11 gene(s)	inside rSNPs	diseases
4	nsv875287	chr2:152714680-153110573	Enhancers Strong transcription Weak transcription Active TSS Genic enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
5	nsv875288	chr2:152716628-153183646	Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Strong transcription Flanking Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
6	nsv875289	chr2:152720030-153183646	Enhancers Weak transcription ZNF genes & repeats Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Strong transcription Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	21 gene(s)	inside rSNPs	diseases
7	nsv875290	chr2:152803129-152920126	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS Bivalent/Poised TSS ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Genic enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	inside rSNPs	diseases
8	esv1847028	chr2:152863856-153045036	Weak transcription Active TSS Bivalent/Poised TSS Strong transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:22 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:152890000-152904400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr2:152899000-152903400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
3	chr2:152899800-152903800	Weak transcription	iPS-15b Cell Line	embryonic stem cell
4	chr2:152899800-152905800	Weak transcription	H1 Cell Line	embryonic stem cell
5	chr2:152899800-152906200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
6	chr2:152900000-152906400	Weak transcription	Fetal Muscle Leg	muscle
7	chr2:152900200-152904400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr2:152901200-152908400	Enhancers	Primary hematopoietic stem cells short term culture	blood
9	chr2:152901800-152908200	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr2:152902200-152903400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
11	chr2:152902200-152904200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
12	chr2:152902200-152907800	Enhancers	Primary hematopoietic stem cells	blood
13	chr2:152902600-152904200	Enhancers	Primary B cells from cord blood	blood
14	chr2:152902600-152904400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr2:152902800-152904200	Enhancers	Primary B cells from peripheral blood	blood
16	chr2:152902800-152904200	Flanking Active TSS	GM12878-XiMat	blood
17	chr2:152903000-152903400	Enhancers	Fetal Kidney	kidney
18	chr2:152903000-152903600	Enhancers	Placenta	Placenta
19	chr2:152903000-152904000	Enhancers	Primary monocytes fromperipheralblood	blood
20	chr2:152903000-152904000	Enhancers	Fetal Brain Male	brain
21	chr2:152903200-152904000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
22	chr2:152903200-152904000	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links